These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5973447)

  • 1. [On the effect of levomycetin resistant Flexner dysentery bacteria on the development of postinfection immunity].
    Sherishorina SI; Arons RM
    Antibiotiki; 1966 Jan; 11(1):51-5. PubMed ID: 5973447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Variability of Flexner dysentery bacteria under the action of neomycin (mycerin) and levomycetin during continuous cultivation].
    Kovalevskaia AN
    Antibiotiki; 1967 Jul; 12(7):606-8. PubMed ID: 5595922
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pathomorphology of experimental Shigella keratoconjunctivitis in relation to the use of levomycetin and pentoxyl].
    Kovalev GK
    Antibiotiki; 1966 Dec; 11(12):1119-23. PubMed ID: 5997608
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative dissemination of the causative agent of dysentery on the Ploskirev medium and Ploskirev medium combined with levomycetin].
    Popova TM
    Antibiotiki; 1966 Sep; 11(9):846-8. PubMed ID: 4871262
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of small doses of levomycetin on the course of experimental dysenterial infection].
    Kovalev GK
    Antibiotiki; 1966 Jun; 11(6):565-7. PubMed ID: 5996872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of media with synthomycine and ribanol to increase the inoculation capacity of dysentery bacteria].
    Grekova AI
    Lab Delo; 1966; 3():181-2. PubMed ID: 4169196
    [No Abstract]   [Full Text] [Related]  

  • 7. [The loss in pathogenicity for mucosa of dysentery bacteria in vitro].
    Stenzel W
    Zentralbl Bakteriol Orig; 1971; 216(1):54-66. PubMed ID: 4928070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of different sensitivity of Shigella to chlortetracycline on the therapeutic effect of this antibiotic].
    Mokrov BA
    Antibiotiki; 1967 Mar; 12(3):230-5. PubMed ID: 5593956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of control over the spread of antibiotic-resistant Shigella strains in the bacteriological diagnosis of dysentery].
    Priamukhina NS; Ershov AA; Staroverova GS; Zimina LG; Shcherbinina VV
    Antibiotiki; 1980 Jun; 25(6):425-9. PubMed ID: 7396440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of neomycin and chloramphenicol against phagocytized Shigella in mouse macrophagues.
    Ondrácek J; Prixová J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(3):303-6. PubMed ID: 5254005
    [No Abstract]   [Full Text] [Related]  

  • 12. [TREATMENT OF EXPERIMENTAL DYSENTERY PRODUCED BY ANTIOBIOTIC-RESISTANT STRAINS OF FLEXNER'S BACILLUS WITH A COMBINATION OF AN ANTIBIOTIC AND A PREPARATION INCREASING IMMUNOGENESIS].
    KOVALEV GK
    Antibiotiki; 1965 Feb; 10():148-51. PubMed ID: 14270126
    [No Abstract]   [Full Text] [Related]  

  • 13. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
    [No Abstract]   [Full Text] [Related]  

  • 14. [Flexner's dysentery bacteria cross effect of chlortetracycline and streptomycine on distribution dynamics of resistance in guinea pigs].
    Vasil'eva NG
    Antibiotiki; 1965 Oct; 10(10):886-9. PubMed ID: 5873005
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the genetics of pathogenicity for mucosa of dysentery bacilli].
    Stenzel W
    Zentralbl Bakteriol Orig; 1971; 216(1):67-78. PubMed ID: 4928071
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 17. [The virulence of Shigellae. Power of intracellular multiplication in macrophage cultures in vitro and keratoconjunctival pathogenic activity in guinea pigs].
    Cefalù M; Puglisi C
    Riv Ist Sieroter Ital; 1967; 42(1):34-50. PubMed ID: 5596587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Keratoconjunctivitis producing pathogenicity of shigella with and without fimbriae in guinea pigs].
    Cefalù M; Puglisi C
    Riv Ist Sieroter Ital; 1967; 42(5):248-57. PubMed ID: 5601684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antimicrobial activity of kalanchoe juice relative to dysentery bacteria].
    Suptel' EA; Lapchik VF; Zagornaia NB; Shirobokov VP
    Mikrobiol Zh (1978); 1980; 42(1):86-90. PubMed ID: 7366486
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test).
    Hanson CE; Ruble GR; Essiet I; Hartman AB
    Comp Med; 2001 Jun; 51(3):224-9. PubMed ID: 11924776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.